Organ-on-chip is a type of an artificial organ that simulates the human organs. It is a multichannel 3D micro-fluidic cell culture device, which stimulates the activities, mechanisms, and physiological response of entire organs. This chip develops a narrow channel for the blood and air flow in organs such as lung, gut, liver, heart, and others. These devices are developed on a microchip that contains continuously perfused chambers colonized by living cells arranged to stimulate tissue and organ level physiology. Organ-on-chip is used to nurture internal organs with the help of silicone.
The organ-on-chip market is driven by increase in applications among the healthcare sector, rise in demand in drug screening, and high demand for lung-based organ culture and kidney application. However, high cost and nascent stage in R&D restrict the market growth. However, increased research activities on organ-on-chip are expected to present an opportunity for market growth.
The organ-on-chip market is segmented on the basis of type and geography. The type segment is divided into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lungs-on-chip. Geographically, the market is analyzed across North America (U.S., Mexico, and Canada), Europe (UK, Germany, France, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
Major companies profiled in the report include Emulate, AxoSim Technologies LLC, CN Bio innovations, Hurel Corporation, Hepregen, Insphero, Mimetas, Nortis, Organovo, and Tara Biosystems.
- Comprehensive analysis of the current trends and future estimations of the global organ-on-chip market is provided.
- The report offers a competitive scenario of the market with growth trends, structure, driving factors, scope, opportunities, and challenges.
- It includes a detailed analysis of the key segments to provide insights on market dynamics.
- Porters Five Forces analysis highlights the potential of buyers and suppliers, and provides insights on the competitive structure of the market to devise effective growth strategies and facilitate better decision-making.
Organ-on-chip Market Key Segmentation:
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Latin America
- Middle East
- AxoSim Technologies LLC
- CN Bio innovations
- Hurel Corporation
- Tara Biosystems